Drugs Made In Stock Analysis

DMAA Stock   10.36  0.01  0.1%   
Drugs Made In is fairly valued with Real Value of 10.23 and Hype Value of 10.36. The main objective of Drugs Made stock analysis is to determine its intrinsic value, which is an estimate of what Drugs Made In is worth, separate from its market price. There are two main types of Drugs Made's stock analysis: fundamental analysis and technical analysis.
The Drugs Made stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Drugs Made's ongoing operational relationships across important fundamental and technical indicators.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Drugs Made In. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Drugs Stock Analysis Notes

About 27.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. To learn more about Drugs Made In call Lynn Stockwell at 954 870 3099 or check out https://dmaacorp.com.

Drugs Made In Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Drugs Made's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Drugs Made In or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
About 27.0% of the company shares are held by company insiders
Latest headline from news.google.com: JNJ vs. PFE Which Blue-Chip Drug Stock is the Better Investment Now - Nasdaq

Drugs Made Thematic Classifications

In addition to having Drugs Made stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Drugs Idea
Drugs
Drug manufacturing and delivery

Drugs Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 343.37 M.

Drugs Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.78)(0.82)
Return On Capital Employed 1.76  1.57 
Return On Assets(0.78)(0.82)
Return On Equity 1.77  1.57 

Technical Drivers

As of the 12th of December 2025, Drugs Made shows the Mean Deviation of 0.106, coefficient of variation of 1768.91, and Downside Deviation of 0.1968. Drugs Made In technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Drugs Made In Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Mid-point over period is an average of Drugs Made In highest and lowest values attained during the given period.

Drugs Made In Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Drugs Made insiders, such as employees or executives, is commonly permitted as long as it does not rely on Drugs Made's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Drugs Made insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Drugs Made Outstanding Bonds

Drugs Made issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Drugs Made In uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Drugs bonds can be classified according to their maturity, which is the date when Drugs Made In has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Drugs Made Predictive Daily Indicators

Drugs Made intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Drugs Made stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Drugs Made Corporate Filings

8K
18th of November 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
17th of November 2025
Other Reports
ViewVerify
12th of November 2025
Other Reports
ViewVerify
14th of August 2025
Other Reports
ViewVerify
10Q
20th of May 2025
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
15th of May 2025
Other Reports
ViewVerify
14th of May 2025
Other Reports
ViewVerify
10K
31st of March 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify

Drugs Made Forecast Models

Drugs Made's time-series forecasting models are one of many Drugs Made's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Drugs Made's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Drugs Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Drugs Made prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Drugs shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Drugs Made. By using and applying Drugs Stock analysis, traders can create a robust methodology for identifying Drugs entry and exit points for their positions.
Last ReportedProjected for Next Year

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Drugs Made to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module

Complementary Tools for Drugs Stock analysis

When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules